Contract award record
Additional Molnupiravir (EIDD-2801/MK-4482) Supply Agreement for Pandemic Purposes
Notice details
- Published
- Category
- goods
- Buyer region
- London
- Source
- View official notice
Public buyer and contract winner
Public buyer
Department of Health and Social Careawarded to
Contract winner
Merck Sharpe & Dohme (UK) LimitedAward value£1
- AwardedCompleted
- StartCompleted
- EndCompleted
Work description
Vaccines have been shown to be highly effective in the fight against COVID-19, to date. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective. There is therefore an urgent need to find an effective alternative. This agreement is for the procurement of 1,750,000 units of Molnupiravir (EIDD-2801/MK-4482). It is one of the first oral and direct-acting antiviral drugs globally and the first to receive regulatory approval and is part of the UK's multi-layered approach to COVID-19.